C.B. Fleet Recalls Phospho-Soda®Products
C.B. Fleet has recalled its Phospho-soda® laxative that it has aggressively promoted since the early 1990s as a safe bowel cleanser for colonoscopy and medical procedure preparation. Phospho-soda® is an over the counter saline laxative consisting mostly of monobasic sodium phosphate monohydrate and dibasic sodium phosphate heptahydrate. It is often taken to prepare for colonoscopy.
Fleet® Phospho-soda® works by drawing liquid from the body into the colon; therefore it can cause severe dehydration that can lead to kidney damage. Phospho-soda® should be used only under the direction of a physician. Since 2004, there have been close to 200 individual lawsuits filed against CB Fleet across the United States. The plaintiffs in these lawsuits allege that they have suffered kidney failure, chronic kidney disease and end stage renal disease as a direct result of using Fleet® Phospho-Soda® in a dose recommended by Fleet as “safe”.
Medical research suggests that the incident rate of kidney failure associated with the use of oral sodium phosphates, such as Phospho-Soda® is 1 in 1000. The kidney damage caused by Phospho-soda is often called Acute Phosphate Nephropathy, Acute Renal Failure, Chronic Renal Failure, or Acute Nephrocalcinosis.
If you or a loved one have suffered kidney disease or kidney damage that developed after taking Fleet® Phospho-soda® as a bowel cleanser in preparation for a colonoscopy or surgery, you may be entitled to monetary compensation for your injury. Call one of our Fleet® Phospho-soda® lawyers today. We want to help.